Marie-Sophie Meuleman

C3 glomerulopathy is a rare disease resulting from an overactivation of the complement alternative pathway. This study found intra-renal terminal pathway activation was associated with specific histological phenotype & disease prognosis in this population bit.ly/JASN0373

You need a reliable measurement of many #complementbiology biomarkers at the same time? Read our new paper about the multiplex assay for complement biomarkers in plasma! Congratulations @MSMeuleman @Duval_anna_ MA Dragon-Durey and team! Happy to take part sciencedirect.com/science/articl…

Petite enquête: Ça vous tenterait de faire un DU «  complément et maladies » qui traiterait de tous les aspects diagnostiques, physiopathologiques et thérapeutiques du complement en médecine?

Now out in our special issue on #C3-targeted #complement #therapeutics! All you need to know about therapeutic C3 modulation in the complex #renal disorder C3 #glomerulopathy #C3G by @MSMeuleman @palheox & @chauvet_sophie sciencedirect.com/science/articl…

Ex vivo test for measuring complement attack on endothelial cells: a promising tool to demonstrate complement activation in human disease 👉🏻 Check our review! 👉🏻 frontiersin.org/article/10.338… @FrontImmunol @chauvet_sophie @roumenina @Duval_anna_ @VeroniqueBacchi @CRCordeliers

Interested on Health Related Quality of Life? Read the first study about long term HRQOL in adults with pediatric onset of frequently relapsing or steroid dependent nephrotic syndrom ! For free here 👉 rdcu.be/cnOcl @audard15 @FiliereORKiD @com_SFNDT @JournalofNeph

Today in print! Check our review on Ex Vivo Complement Activation on Endothelial Cells: Research and Translational Value For all fans of #endothelial cells and #complementbiology Great job @SophieMeuleman @chauvet_sophie @VeroniqueBacchi @CRCordeliers sciencedirect.com/science/articl…